The retinoic acid receptors (RAR) belong to the large family of ligand responsive gene regulatory proteins that includes receptors for steroid and thyroid hormones. These proteins contain two highly conserved domains, involved In determining their DNA and ligand binding activities. Three distinct RARs have been identified (RARa, /3, and 7) which are encoded by genes on separate chromosomes. Additional isoforms of the three receptors have been described that all differ in the N-terminal regions. To gain insight Into the genomic organization and mechanisms of RAR isoform generation, we have analyzed the genomic structure of the RAR7 gene. The major portion of the RAR7 protein, including DNA and ligand binding domains, is encoded by seven exons that are identical for all RARg Isoforms and are represented by a relatively small portion of the RAR7 gene. The major portion of this gene encodes separate N-terminal exons for 71 and 72 isoforms and several exons for 7I untranslated regions. We show that RAR72 transcription Is regulated by its own promoter. In comparison with the steroid receptor subfamily, various splice sites of RAR7 occur at altered positions, suggesting that the RAR subfamily has diverged early during evolution.
INTRODUCTION
Retinoic acid (RA) is a vitamin A metabolite, which exerts essential effects in the control of epithelial cell growth, fetal development, cellular differentiation (1) , and has recently been identified as a natural morphogen conferring pattern formation of the regenerating amphibian and chick limb bud (2,3). A potential model for the molecular mechanism underlying these pleiotropic effects was provided by the identification of RA receptors (RARs) as members of the steroid/thyroid hormone receptor superfamily (4) (5) (6) (7) . These are ligand-activated transcription factors which interact specifically with cognate DNA elements (i.e. hormone response elements) to modulate transcription (reviewed in refs. 8, 9) . They all contain a highly conserved DNA-binding domain of the 'zinc-finger' type and a predominantly hydrophobic ligand-binding domain that also encodes the receptor dimerization function (10) (11) (12) .
The isolation of three different human RAR subtypes: RARa (4,5), RAR/3 (6, 7), and RAR7 (13, 14) suggests that these have different functions and may activate distinct target genes. The three RAR genes reveal a spatially and temporally restricted expression pattern during mouse embryogenesis. The RAR7 expression pattern suggests a crucial role in the regulation of gene expression during morphogenesis and differentiation of squamous epithelia (15, 16) . Our recent finding that RAR/3 and RAR7 show distinct activation profiles of the two different RA response elements,TRE-pal and /3RARE, indicates for the first time the existence of RAR target gene specificity (17) . Since both RARs appear to bind equally to both response elements, their differential activation capacity might be attributed to their different N-terminal regions. This region is highly divergent among RARs but is highly conserved between different species for the same RAR isoform (18) .
Recently, a second human RAR7, designated as the RAR72, was isolated. This differs from RAR7I (former RAR7) in the N-terminal region but is otherwise identical (13, 14, 18) . The thyroid hormone receptors (TRs) exist also as variants that differ either in their amino-or carboxy-terminal ends (19-21 and references therein). TR-a splice variants with altered C-terminal portions, are not transcriptional activators but acts as hormoneindependent repressors (19, Herrmann et al., submitted). The delineation of mechanisms that generate expression of functionally distinct RAR isoforms will provide insight into the highly specific network that allows the single substance, RA, to have cell lineage specific regulatory functions.
To determine the mechanisms regulating the synthesis of the different RAR7 isoforms and to show how the exon structure contributes to the functional domains, the genomic organization of the RAR7 gene was determined. The 3'-third of the gene was found to contain almost all coding exons except for the N-terminal A-region exon. The exons encoding the alternative A-regions of RAR7I and RAR72 are contained in the first two-thirds of the RAR7 gene. We show that RAR72 transcription is regulated by its own promoter. Comparison of the RAR7 exon structures with those of steroid hormone receptors suggest that the RAR subfamily developed independently from the steroid receptor subfamily.
MATERIALS AND METHODS
Isolation and sequencing of human RAR7 cDNA and genomic clones The RAR7I cDNA clone was obtained from screening a human placental Xgtll expression library (22) kindly provided by J.L. Millan from this institute. A random primed ^P-labeled cDNA comprising the ligand-binding domain of RARa was used as a hybridizing probe. This cDNA fragment was obtained by using the PCR-technique and phage DNA from the same placental library (23) . Standard hybridization and stringent washing conditions were used (24) . By using the 5' AccI fragment derived from cDNA clone RAR7I (position 1 -403) as a probe, two clones designated as RAR7 gcnel _ 2 were isolated from a human genomic placental library (Stratagene). Genomic walking using 5'-sequences of RAR7 gcne , (327 bp Sstl-PstI fragment) led to the isolation of RAR7 gene3 . For sequencing, suitable restriction fragments of both the cDNA and the genomic clones were subcloned in Bluescript and double-stranded cDNA was sequenced using the dideoxynucleotide chain-termination method (25) with Sequenase (United States Biochemical).
Transient transfection of CV-1 cells
CV-1 cells were seeded at a density of 1.3 X10 6 per plate in DMEM supplemented with 10% fetal calf serum. The following day, cells were transfected with 1/ig of expression plasmids and 4 ng of CAT reporter plasmids using a modified calcium phosphate precipitation procedure (23, 26) . As internal transfection standard, 3/tg of /3-galactosidase gene (pCHHO, Pharmacia) were cotransfected. CAT and /3-galactosidase activity were determined as described previously (23) .
Primer extension analysis
The end-labeled oligonucleotide primer (5'-TTAAAAGCGAA-CGCTGGAGGGGT-G-3' annealing to the region +317 to +341 of exon Id) was extended using 50 U MoMLV reverse transcriptase (BRL), cold deoxynucleotides and 50 /ig of total RNA derived from the human lung cell line WI-38 (American Type Culture Collection, Ma) as template. The resultant cDNA was analyzed on a sequencing gel.
RESULTS AND DISCUSSION
Isolation of RAR7 cDNA clones and functional analysis To allow structural analysis of the RAR7 receptor, cDNA clones were isolated from human cDNA libraries including HL-60 cells, primary keratinocytes, and placental tissue. The longest cDNA clone, RARgl, was isolated from a placental Xgtll expression library using a random primed Retfatcteadd (Mx-log) in the 3'-untranslated region suggesting a short half-life of RAR7 mRNA (27) . In comparison to the sequence of RAR7 published by Krust et al. (13) , the RAR7I cDNA sequence is 938 bp longer in the 3'-untranslated regions, reveals one silent point mutation (Pro-75 [CCA-CCC]), and did not contain the nucleotide A-1888 (numbering according to Krust et al., [13] ). These findings were confirmed later by the genomic sequence.
To analyse the biological activity of the encoded RAR7 protein, we inserted the coding sequence into a eukaryotic expression vector (pECE) and cotransfected pECE-RAR-y together with a RA-responsive reporter gene (TRE2-/& CAT) into CV-1 cells. TRE2-flt CAT contains two RA-responsive elements upstream of the HSV-flk gene promoter pBLCAT2 construct (28, 29) . We observed that addition of RA resulted in a concentration dependent activation of the reporter gene (Figure 2 ). RAR7I shows higher basal level activity than RAR/3, shown here as a control, and displayed a more sensitive response to RA than RAR/3. Our data clearly demonstrates that the isolated cDNA clone encodes an active RAR7I protein.
Structural organization of the RAR7 gene
Two overlapping clones (RAR7 gcne i_ 2 ) were isolated from a human genomic placental X FIX II library using RAR7 cDNA as a gene. A third clone (RAR7 gene3 ) was isolated using a probe derived from the 5'-end of clone RAR7 geoe i. Figure 3 shows the restriction map covering approximately 38 kb of genomic sequence. To delineate the exon-intron organization, the coding exons and flanking intron regions were sequenced (Figure 1 ). Intron/exon boundaries have the canonical consensus splice sequences. The complete gene is composed of eleven exons, of which ten are used for the RAR7I transcript ( Figure 3 , exons la, Ib, Ic, and n-VTfl). The most 5'-exons of RAR7I is not contained in the 38 kb sequence, but is predicted from the cDNA sequence (13) . An additional exon (Exon Id) defining the RAR72 5'-message was detected within intron 3 of the gene (Figure 3) . Seven exons-common to all RAR7 isoforms-are containing the complete RAR7 coding sequence with the exception of the N-terminal domain, and were located within approximately 5 kb of the 3'-end of the RAR7 gene. This rather compact portion of the gene may represent an ancestral version of the RAR7 gene since an RAR7I protein deleted for the A-region has transactivation properties similar to RAR72 (data not shown).
Exon structures common for RAR7 isoforms From the eleven RAR7 coding exons, seven (exons II to VOT) are common to all RAR7 isoforms. They encode domains B through F and the entire 3'-untranslated region as shown in Figure  3 . Exon II (Ser-62 to Lys-111) encodes the entire B-region together with the first 'zinc-finger' of the DNA-binding domain. This is in contrast to steroid receptors which encode the large A-region together with most of the B-region in a single exon (30) (31) (32) (33) receptor with high sequence homology to the nuclear receptor superfamily, contains a third alternative position for the splice site (35) . For the glucocorticoid receptor a region designated the P-box, located at the base of the first finger, seems to be critical for the identification of cognate DNA sequence. A second element, the D-box, is involved in the determination of the spacing between the response element half-sites (36) (37) (38) . Similar P-and D-box motifs were found in all nuclear receptors. Interestingly the P-box motifs of RARs,TRs, and the estrogen receptor are identical (i.e. EGCKG, single letter amino acid code) which may explain the binding of all three receptor types to overlapping sets of response elements (i.e. TRE,^ and RARE /3-gene-promoter; 17, 28, 29, 38) . Since both 'zinc-fingers' seem to have different functions and their amino acid sequence is also highly divergent outside the cysteines, it is possible that both exons have developed separately rather than by exon duplication. Exon IV encodes the hinge region located between the DNA binding and the RA binding domain. The splice site between exons in and IV is located within a region conserved in all nuclear receptor genes known so far.
The hormone binding domain is encoded by the exons V (Asn-213 to Leu-271), VI (Met-272 to Gly-339), VH(Asp-340 to Lys-391), and by parts of exon Vm(Gly-392 to Met^21). The remainder of exon VIE encodes for the rest of the molecule and the entire 3'-untranslated region. This exon-intron structure of the RAR7 gene in the hormone binding domain is different from that found in steroid receptor genes, except for the location of the splice junction within the heptad repeat (Figure 4) . The heptad repeat (located between amino acids 373 -407 in RAR7) has been proposed to mediate the receptor dimerization function and is distributed on the exons VQ and VIE. Fawell et al. (10) have recently observed that the N-terminal portion of this heptad repeat, namely that encoded by exon VH forms part of the dimer interface, while the C-terminal part may contribute to the generation and/or stability of the estrogen receptor-dimer structure. The RA binding function has not yet been assigned to a specific region within the large hydrophobic ligand binding domain. Mutational analysis performed in the estrogen receptor indicates that residues 518 to 525 (i.e. overlapping with the heptad repeat) are essential for hormone binding (10) .
the region encoding the A-region of RAR72 was identified within the 11.0 kb intron located between exons Ic and II. This exon, designated exon Id, is located about 7 kb downstream of exon Ic and encodes 50 amino acids ( Figure 5 ). Amino acid sequence comparison showed a considerable homology with the A-region of RAR/3 which is most striking around two cysteines and two prolines, suggesting a sandwich-like structure of/3-sheets ( Figure  6 ). The functional significance of this (i.e. possible interaction with common transcription factors) remains to be analyzed. Analysis of genomic sequences upstream to sequences homologous with the longest human cDNA clones described, revealed a high sequence homology (83%) up to the position +328 with the entire 5'-untranslated region described for mouse cDNA clones (18) . This excludes the presence of intronic sequences. The high conservation of the 5'-untranslated region may also indicate a functional importance of this region. Primer extension analysis using total RNA derived from WI-38 human lung cells as template, defines two major transcription start points (+1 and +5, Figure 7 ). This indicates that alternative promoter usage rather than alternative splicing is directing RAR72 synthesis. The sequence motif TTATG at position -34 may serve as a weak TATA-box. The close proximity of the RAR72 aminoterminal coding exon to the RAR7 common coding sequences and the homology observed in the amino acid sequence with RAR/3 suggest an earlier connection of this exon with RAR7 than with the RAR7I specific exons.
CONCLUSION
Retinoic acid and the thyroid hormones exert profound functions in such complex processes as tissue development and differentiation. The nuclear receptors binding these molecules 
Intron exon structures for distinct RAR7 isoforms
Exon Ic encodes 142 bp of the 5'-untranslated region and the first 61 amino acids. This exon is unique for RAR7I and distinguishes this isoform from RAR72 (13) . We have recently found that this part of the N-terminal region is not necessary for the gene activation functions of RAR7I, since a protein lacking this region is still a potent activator of RARE containing promoters (unpublished data, Husmann, JML, MP). The mRNAs encoding RAR isoforms lacking this sequence also appear to be produced in certain tissues (18) . It is therefore possible that the exon Ic is a relatively late addition to the RAR7 gene. RAR7I contains at least two additional exons for 5'-untranslated regions (Figure 3) , one of which, exon la, is not included on the 38 kb analyzed here, and exon Ib which encodes further 67 bp of the 5'-untranslated region. Thus the RAR7I promoter region is located far upstream of the major RAR7 coding sequences.
As mentioned above two distinct RAR7 isoforms have been isolated recently. RAR7I and RAR72 differ completely in their N-terminal regions while the remainder of the molecule is identical, suggesting that they are derived from a single gene locus. Using restriction analysis and RAR72 specific primers, Figure 7 . Analysis of the transcription start point of the RAR-y2 by primer extension analysis. An end-labeled primer (see materials and methods) was extended by using total RNA from human WI-38 lung cells as template (lane 1). For size verification a sequencing reaction terminated with ddCTP and using the same primer is shown (lane C). The sequence flanking the transcription start point is shown. The asterisks indicate the two major transciption start points.
are structurally highly related and form a subfamily within the steroid/thyroid hormone receptor superfamily. These receptors combine various functional properties such as sequence specific DNA binding, ligand binding, ligand dependent and independent fra/ts-activation, receptor-dimerization, and nuclear localization. Genomic analysis revealed that the exon-intron structure of the RAR7S is distinct from that found in the steroid receptors (i.e. differences in the length of exons and position of various splice sites). This suggests that during evolution, the TR/RAR subfamily has developed independently from the other nuclear receptors. Noteworthy is that the organization of nuclear receptors into A-F domains based on sequence homology is not strictly consistent with the exon-intron structure. A second important difference within the RAR/TR subfamily is their capability to generate variants with distinct amino-or carboxy-terminal regions. Northern blot analysis revealed spatio-temporal differences in the expression of these variant receptors during embryogenesis (16, 18) . Based on the structural similarity of the DNA binding domain, TRs and RARs can bind to common response elements, however rrans-activation may need interactions with other tissue specific transcription factors. Interactions may be elicited by the different N-terminal regions which have been shown to confer tissue specific /ra/is-activation function in other nuclear receptors (33, 39, 40) . The compact organization of the major portion of the RARy coding sequence compared to the diffuse organization of the amino-terminal coding sequences suggest independent origins for these two portions of the RARy gene. The compact RARy basic structure may represent the ancient RARy gene where the large 5'-region of the gene may be a relatively new addition that allows increased flexibility for RARy regulation and isoform expression using multiple promoters.
